newdrugapprovals.org
FDA approves new combination treatment for acute myeloid leukemia, Rydapt (midostaurin)
MIDOSTAURIN FDA approves new combination treatment for acute myeloid leukemia 04/28/2017 The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patient…